image
argenx SE ARGX
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 564.225
-5.18 %
$ 33.7 B
Market Cap
-732.76
P/E
INCOME STATEMENT
1.23 B REVENUE
198.56%
Growth Rates
1Year 198.56%
3Years 201.37%
5Years 118.59%
7Years 86.76%
10Years 78.68%
-425 M OPERATING INCOME
40.94%
Growth Rates
1Year 40.94%
3Years 6.13%
5Years -35.33%
7Years -52.15%
10Years -47.70%
-425 M NET INCOME
40.99%
Growth Rates
1Year 40.99%
3Years 6.13%
5Years -35.33%
7Years -52.15%
10Years -47.70%
EFFICIENCY
Earnings Waterfall argenx SE
image
Revenue 1.23 B
Cost Of Revenue 118 M
Gross Profit 1.11 B
Operating Expenses 1.53 B
Operating Income -425 M
Other Expenses 0
Net Income -425 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 1 226.3 410.7 497.3 44.8 78.2 24.6 43.7 15.5 7.5 4.6 3.7 2.2 1.5
GROSS PROFIT
Cost Of Revenue 117.8 29.4 510.0 303.6 196.8 0 0 0 0 0 1.0 0 0
Gross Profit 1 108.5 381.3 (12.8) (258.8) (118.6) 24.6 43.7 15.5 7.5 4.6 2.7 2.2 1.5
OPERATING INCOME
Operating Expenses 1 533.5 1 101.0 846.0 561.8 279.4 118.2 71.2 38.0 24.6 17.6 12.3 15.5 6.2
Selling, General and Administrative Expenses 709.5 472.1 307.6 183.7 72.3 31.4 14.9 7.4 5.4 4.2 2.9 2.7 2.5
Research and Development Expenses 755.1 663.4 580.5 400.3 221.4 95.6 62.1 33.2 22.6 15.4 12.9 14.6 6.3
Operating Income (425.0) (719.7) (348.7) (513.8) (200.0) (93.6) (27.5) (22.5) (17.1) (13.1) (8.6) (13.3) (4.7)
PRE-TAX INCOME
Interest Income Expense 0.9 3.9 1.1 1.7 0.1 0 5.7 0 0 3.65 K 5.52 K 2.65 K 1.3 K
Total Other Income 120.6 (5.0) (35.0) (127.7) 21.6 16.0 (4.5) 44.2 K 0.3 0.5 0.1 0.5 0.2
Pre-Tax Income (304.5) (729.3) (399.7) (647.1) (177.2) (75.3) (33.0) (22.5) (16.7) (12.5) (8.5) (12.8) (4.5)
NET INCOME
Tax Provision (9.4) (19.7) 8.5 3.4 5.3 0.9 0.7 20 K (0.2) (0.4) 0.1 7.94 K 22 K
Net Income (295.1) (709.6) (408.3) (650.5) (182.5) (76.2) (33.7) (22.5) (16.7) (12.5) (8.5) (12.8) (4.5)
EPS 5.16 13.1 7.99 14.3 4.73 2.12 1.37 1.19 1.06 1.66 0.54 0.82 0.29